Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf324 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Barbara A Gower und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Sciences, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Liver, Diet, Carbohydrate-Restricted, Diet, Ketogenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: UAB Nutrition Obesity Research Center, NIH HHS, UAB Diabetes Research Center.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Carbohydrate restriction benefits metabolic health in patients with type 2 diabetes (T2D), possibly through changes in hepatic metabolism.
Objective
To test the hypothesis that the ketogenic diet (KD) would decrease de novo lipogenesis (DNL) and liver fat, which would be associated with restored beta-cell function.
Methods
Participants were 57 adults with mild T2D. A hyperglycemic clamp was used to assess acute C-peptide response (ACP), and magnetic resonance imaging to assess hepatic fat fraction, at baseline and after 12 weeks of either a eucaloric KD (∼9% energy from carbohydrate, 65% energy from fat) or a eucaloric low-fat diet (LFD) (∼55% energy from carbohydrate, 20% energy from fat).
Results
The KD led to decreases in pyruvate (−23%, P < .001) and palmitoleic acid, a marker of DNL (−32%, P < .01). Participants on the KD had higher fasting glucagon (25%, P < .05) and lower liver fat (28%, P < .05) at week 12 than those on the LFD. In all combined, the change in liver fat was positively associated with the change in pyruvate (r = 0.45, P = .05), and inversely associated with changes in glucagon (r = −0.34, P < .05), the glucagon to C-peptide ratio (r = −0.44, P < .01), and ACP (r = −0.34, P < .05). The change in ACP was inversely associated with the change in pyruvate in the KD group (r = −0.5, P < .05), but not in the LFD group.
Conclusion
A shift in hepatic metabolism to favor fat oxidation over DNL may underlie the beneficial effects of carbohydrate restriction on hepatic steatosis and glucose-induced insulin secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Sciences, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Department of Urology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
ORCID-Profile: Barbara A Gower, Marian L Yurchishin, Amy M Goss, John Knight, William T Garvey
Förderung
- UAB Nutrition Obesity Research Center
- NIH HHS
- UAB Diabetes Research Center
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Gower, B. A., Yurchishin, M. L., Goss, A. M., Knight, J., & Garvey, W. T. (2025). Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf324
Vancouver
Gower BA, Yurchishin ML, Goss AM, Knight J, Garvey WT. Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf324
BibTeX
@article{Gower2025,
author = {Gower, Barbara A and Yurchishin, Marian L and Goss, Amy M and Knight, John and Garvey, William T},
title = {Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf324}
}
EUVIMED